CIURLEO, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.389
EU - Europa 1.012
AS - Asia 326
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 2.730
Nazione #
US - Stati Uniti d'America 1.382
SE - Svezia 331
IE - Irlanda 327
CN - Cina 217
UA - Ucraina 98
DE - Germania 80
IT - Italia 67
VN - Vietnam 52
FI - Finlandia 46
SG - Singapore 39
GB - Regno Unito 25
IN - India 15
AT - Austria 10
BE - Belgio 8
CA - Canada 7
NL - Olanda 7
RU - Federazione Russa 5
FR - Francia 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
EU - Europa 1
LA - Repubblica Popolare Democratica del Laos 1
PT - Portogallo 1
RO - Romania 1
Totale 2.730
Città #
Dublin 327
Chandler 315
Nyköping 222
Jacksonville 193
Ashburn 104
Dearborn 87
Beijing 78
Princeton 56
Dong Ket 52
Medford 49
Cambridge 46
New York 44
Boardman 43
Des Moines 43
Singapore 28
Jinan 23
Ann Arbor 18
Nanjing 18
Hebei 17
Wilmington 12
Woodbridge 12
Bremen 11
Messina 11
Vienna 9
Brussels 8
Hyderabad 8
Los Angeles 8
Taiyuan 8
Taizhou 8
Lancaster 7
Washington 7
Montréal 6
Shenyang 6
Nanchang 5
Tianjin 5
Catania 4
Changsha 4
Fuzhou 4
Haikou 4
Hefei 4
San Mateo 4
Seattle 4
West Jordan 4
Zhengzhou 4
Falls Church 3
Hangzhou 3
Jiaxing 3
Mcallen 3
Milan 3
Munich 3
Pietra Ligure 3
Turin 3
Auburn Hills 2
Campi Bisenzio 2
Chicago 2
Guangzhou 2
Helsinki 2
Houston 2
Kunming 2
London 2
Monmouth Junction 2
Ningbo 2
Nuremberg 2
Pavia 2
Pune 2
Wuhan 2
Xian 2
Albuquerque 1
Amsterdam 1
Berlin 1
Brno 1
Brooklyn 1
Canelli 1
Canton 1
Cedar Knolls 1
Chengdu 1
Clearwater 1
Edinburgh 1
Giarre 1
Hanover 1
Lausanne 1
Lecce 1
Lisbon 1
Mansfield 1
Meppel 1
Nanning 1
New Delhi 1
Newark 1
Norwalk 1
Perugia 1
Porto Potenza Picena 1
Quzhou 1
Redwood City 1
Rende 1
Rome 1
San Giovanni La Punta 1
Sant'Agata di Militello 1
Santa Clara 1
Serra 1
Tavernerio 1
Totale 2.017
Nome #
(1)H-MR Spectroscopy in Traumatic Brain Injury. 206
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 76
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 73
1H Magnetic Resonance Spectroscopy of the brain: methods for absolute quantification of metabolites 70
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 69
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 68
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 68
Diffusion - weighted imaging and fluid-attenuated inversion recovery sequence in sporadic Creutzfeldt-Jakob disease. One - case report. 68
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 64
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 64
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 64
Functional connectivity in vegetative state patients 64
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 62
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy. 60
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 59
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 57
Neurophysiological approach in comatose patients 57
Automatic Algorithm for Segmentation of Atherosclerotic Carotid Plaque 57
Functional neuroimaging in differential diagnosis and outcome assessment of patients with disorders of consciousness 56
Reality orientation therapy (ROT) in Alzheimer’s disease. 54
ROLE OF MAGNETIC RESONANCE SPECTROSCOPIC IN THE METABOLIC CHANGES IN DE NOVO PARKINSON’S DISEASE AFTER DOPAMINERGIC THERAPY 54
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 53
Functional evaluation of awareness in vegetative and minimally conscious state 52
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 51
“2,4-Thiazolidinedione derivatives as potential agents for the treatment of type 2 diabetes and its chronic complications” 49
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 45
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 45
The clinical use of quality of life scales in the neurodegenerative diseases 44
ROLE OF RESVERATROL AND ITS ANALOGUES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES: FOCUS ON RECENT DISCOVERIES, 44
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 41
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 41
RUOLO DELLA RISONANZA MAGNETICA SPETTROSCOPICA NELLO STUDIO DELLE ALTERAZIONI METABOLICHE NELLA MALATTIA DI PARKINSON IN SEGUITO A TERAPIA DOPAMINERGICA 40
Evaluation of olfactory dysfunction in neurodegenerative diseases. 40
The role of sativex in robotic rehabilitation in individuals with multiple sclerosis rationale, study design, and methodology 40
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia 39
Neurorehabilitation as a multidisciplinary approach: amyotrophic lateral sclerosis 38
Evaluation of olfactory dysfunction in neurodegenerative diseases 38
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries 37
null 37
Titolo: Ruolo della risonanza magnetica spettroscopica nello studio delle alterazioni metaboliche nella malattia di Parkinson in seguito a terapia dopaminergica 35
Post-traumatic olfactory loss: Psychophysical, electrophysiological and neuroradiological findings in three single case studies 32
Effects of diffusion signal modeling and segmentation approaches on subthalamic nucleus parcellation 30
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 30
Role of statins in the treatment of multiple sclerosis 30
Propranolol for familial cerebral cavernous malformation (Treat_CCM): Study protocol for a randomized controlled pilot trial 30
Olfactory event-related potentials in a functionally anosmic patient with arrested hydrocephalus 29
Transcriptomic data analysis reveals a down-expression of galectin-8 in schizophrenia hippocampus 29
Neurogenic ejaculatory disorders: focus on current and future treatments. 28
Ventral intermediate nucleus structural connectivity-derived segmentation: anatomical reliability and variability 28
In vivo probabilistic atlas of white matter tracts of the human subthalamic area combining track density imaging and optimized diffusion tractography 28
White matter substrates of functional connectivity dynamics in the human brain 27
Persistent anosmia in a traumatic brain injury patient: role of orbitofrontal cortex. 25
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study 24
The role of brain oscillations in post-stroke motor recovery: An overview 23
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson’s Disease? 23
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior 22
In Vivo Super-Resolution Track-Density Imaging for Thalamic Nuclei Identification 21
Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility? 17
Role of diffusion tensor imaging in the diagnosis and management of post-traumatic anosmia 5
Totale 2.760
Categoria #
all - tutte 11.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020339 0 0 0 18 22 67 87 52 5 21 65 2
2020/2021281 34 0 41 14 16 38 0 18 1 32 21 66
2021/2022334 2 24 7 8 31 1 55 6 8 15 48 129
2022/20231.122 95 114 44 97 92 124 27 56 425 8 28 12
2023/2024312 21 45 22 35 30 96 1 20 2 14 6 20
2024/202557 7 15 35 0 0 0 0 0 0 0 0 0
Totale 2.760